5-fluorouracil induces defects in platelet function

Platelets

Volumn 10, Issue 2-3, 1999, Pages 137-140

  Kumar, Anand ^a,b   Kumar, Rajeev ^a   Sandilium, Amitabh ^a   Shukla, Jyoti ^a   Pradhan, Satyajit ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; FLUOROURACIL; THROMBOCYTE FACTOR 3;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CHEMOTHERAPY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA;

EID: 0032961207     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109909169176     Document Type: Article

References (20)

1. 1. White JG. Effect of colchicine and vinca alkaloids on human platelet: influence on primary internal contraction and secondary aggregation. Am J Pathol 1969; 54: 467-73.
2. 2. Steinherz PG, Miller DR, Hilgartner MW, Schmalzer EA. Platelet dysfunction in vincristine treated patients. Br J Haematol 1976; 32: 439-50.
3. 3. Ahr DJ, Scialla SJ, Kimball DB. Acquired platelet dysfunction following Mithramycin therapy. Cancer 1978; 41: 448-54.
4. 4. Shapiro RS, Gerrad M, Ramsay NK et al. Selective deficiency in collagen induced platelet aggregation during L-asparginase therapy. Am J Pediatr Hematol Oncol 1980; 2: 207-12.
5. 5. Pui CH, Jackson CW, Chesney C. Sequential changes in platelet function and coagulation in leukemic children treated with L-arparginase, prednisolone and vincristine. J Clin Oncol 1983; 1: 380-5.
6. 6. Kumar A, Khanna NN, Gupta YN. Qualitative platelet dysfunction following cancer chemotherapy: a case report. J Surg Oncol 1984; 25: 176-7.
7. 7. Kumar A, Chaturvedi P, Gupta YN. Combination chemotherapy for breast carcinoma using a combination of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) causes a platelet aggregation defect. Int J Cancer 1996; 66: 159-61.
8. 8. Goodnough LT, Saito H, Manni A, Jones PK, Pearson OH. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five drug chemotherapy regimen: a study of 159 patients. Cancer 1984; 54: 1264-68.
9. 9. Canobbio L, Fassio T, Ardizzoni A, Bruzzi P, Queirolo MA, Zarcone D, Di Giorgio F, Rosso R, Santi L. Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients. Cancer 1986; 58: 1032-6.
10. 10. Ruiz MA, Marugan I, Estello A, Naurro J, Espana F, Alberola V, San-Juan L, Aznar J, Garcia-Conde J. The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients. 1989; 63: 643-48.
11. 11. Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990; 65: 885-9.
12. 12. Takano S. Effect of antitumor drug on dog platelet aggregation. Fukushima Med J 1978; 28: 227-33.
13. 13. Chabner BA. Anticancer drugs. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer - Principles and Practice of Oncology, 4th edn. Philadelphia: J.B. Lippincott, 1993; 325-417.
14. 14. Dobbs RM, Barber JA, Wenigel JW, Bergin JE. Clotting predisposition in carcinoma of the prostate. J Urol 1980; 123: 706-9.
15. 15. Panella TJ, Peters W, White JG, Hannun YA, Greenberg CS. Platelets acquire a secretion defect after high-dose chemotherapy. Cancer 1990; 65: 1711-6.
16. 16. Gagliano RG, Terrebonne AM, Alperin JB, Costanzi JJ. The effect of cytosine arabinoside on platelet aggregation. Cancer 1976; 38: 2247-9.
17. 17. Sbalzarini G, Pandolfi C, and Labadini A. Platelet aggregation during adjuvant chemotherapy with CMF (English abstract). Minerva Med 1991; 82: 367-70.
18. 18. Mahraj D, Ledford MR, Chatoor H. High dose chemotherapy induced abnormal platelet function in bone marrow transplantation patient. Blood 1993; 82(Suppl 1): 609.
19. 19. Karolak L, Chandra A, Khan W, Marks B, Petros WP, Greenberg CS, Hannun YA. High dose chemotherapy induced paltelet defect: inhibition of platelet signal transduction pathway. Mol Pharmacol 1992; 43: 37-44.
20. 20. Hokom MM, Hunn P, Amgen L. Both mitotic and maturation factors are affected in mouse megakaryocyctes following 5-FU administration. Blood 1993; 82 (Suppl): 10.